neck arising from the proximal M 1 segment. The angioarchitecture of the aneurysm was characterized by a 6-mm neck with an aspect ratio of 1.83 (Fig. 1C) . Contrast-enhanced images revealed decreased opacification within the right hemisphere consistent with slow flow within the right MCA (Fig. 1D ). These imaging characteristics were consistent with a partially thrombosed right M 1 segment aneurysm leading to thromboembolism within the lateral lenticulostriate vessels and thus infarction of the right corpus striatum and internal capsule. Given the age of the patient and the need for anticoagulation due to infarction, we opted to proceed with cerebral angiography and potential embolization on hospitalization Day 2.
Treatment. The patient received dual antiplatelet medications (clopidogrel bisulfate 4 mg and aspirin 40 mg) prior to the procedure. After inducing general anesthesia via endotracheal tube and utilizing a routine sterile technique, we introduced a 4-Fr Pinnacle sheath (Terumo) into the left common femoral artery with the aid of ultrasound guidance. A 4-Fr Glidecath (Terumo) was advanced to the horizontal segment of the right petrous internal carotid artery. Under roadmap guidance, the right M 2 segment was selectively catheterized using an XT microcatheter (Stryker), and a 3 × 20-mm Neuroform EZ stent (Stryker) was deployed across the aneurysm neck ( Fig. 2A and B ). An SL-10 microcatheter (Boston Scientific) was advanced through the stent into the aneurysm, which was then obliterated with Target detachable coils (Stryker). Postembolization runs revealed thrombus formation at the distal portion of the stent (Fig. 2C) . The SL-10 microcatheter was removed from the aneurysm and placed within the thrombus, allowing the administration of 2 mg of abciximab (Eli Lilly) within the thrombus, leading to complete patency of the vessel (Fig. 2D) . There was no evidence of a delay in transit time, and distal vessels were patent.
Posttreatment Course. The patient was admitted to the neonatal intensive care unit and maintained on 4 mg of clopidogrel bisulfate and 40 mg of aspirin daily. Following the procedure, the patient remained at baseline with left-sided hemiparesis. Cerebral angiography 24 hours postembolization revealed complete obliteration of the aneurysm dome with patency of M 1 and partial resolution of the preprocedural M 1 stenosis (Fig. 3) . The patient was discharged to home on Day 7 with symmetric facial movements and an improving left-sided hemiparesis. Mild language delay was detected at an age of 21 months; however, the patient continues to achieve appropriate milestones as he grows into childhood. Clopidogrel bisulfate was discontinued 6 months following the procedure, while aspirin has been continued. Follow-up MRI and/or MRA were performed at 2 months and revealed chronic ischemic changes within the right basal ganglia and internal capsule. The aneurysm remained obliterated, while the MCA was patent with no evidence of stenosis. Repeated MRI and/or MRA at 6, 12, 18, and 24 months postembolization displayed stable aneurysmal healing with minimal stable filling at the aneurysm neck (Fig. 4) .
Discussion
Pediatric cerebral aneurysms are rare and account for less than 5% of all intracranial aneurysms. 5, 6, 9, 22, 25, 26, 30 Such aneurysms tend to be larger, more complex in angioarchitecture, and have a higher incidence in boys, as compared with cerebral aneurysms in the adult population. Seventysix percent of pediatric aneurysms are located in the anterior circulation, with MCA aneurysms three times more prevalent than other anterior circulation locations. 5 In addition, patients presenting with hemorrhage are younger (mean age 4.3 vs 6.7 months, respectively) and tend to have smaller aneurysms than those presenting with nonhemorrhagic symptoms. Our case-a 9-month-old male infant harboring a large MCA aneurysm who presented with an acute neurological deficit in the setting of an ischemic stroke-is consistent with the above characteristics. In addition, 21% of pediatric aneurysms can be associated with trauma or connective tissue disorders (polycystic kidney disease, collagen vascular disease, or aortic coarctation); 5 however, this was not the case in our patient.
The most appropriate treatment for pediatric cerebral aneurysms is currently under debate, and updated guidelines have yet to be defined. Contemporary endovascular and microsurgical techniques are considered equivalent in effectiveness and safety when used in appropriate pediatric cases. 31 Extrapolating from adult trials, such as the Barrow Ruptured Aneurysm Trial (BRAT) and the International Subarachnoid Aneurysm Trial (ISAT), it is plausible that endovascular methods will provide better outcomes than microsurgical treatment. 1, 23, 24 In addition, there is minimal tolerance for blood loss in younger patients, thus making microsurgery much more challenging.
The existing literature indicates that microsurgical therapy leads to higher rates of complete aneurysm obliteration (92%-93% vs 79%-82% for endovascular treatment) and lower rates of recurrence (0% vs 14% for endovascular treatment) in children. 27 Despite the reported superiority of the open surgical approach as regards obliteration and recurrence rate, the last few decades have witnessed a change of paradigm characterized by a gradual shift from traditional microsurgical approaches toward endovascular treatment of aneurysms in adults and pediatric patients. 2, 33 The ongoing shift was strengthened in 2002 with the publication of the ISAT, which reported a statistically significant 7.4% absolute 1-year disabilityfree survival advantage favoring coiling. 23, 24 Unfortunately, wide-necked (neck > 4 mm or aspect ratio < 2) and fusiform aneurysms were typically not included in that study; thus, the standard of care for these aneurysms is still under debate.
As mentioned earlier, wide-necked aneurysms remain a challenge for neurosurgeons and interventional radi- ologists. 12, 20 In the pediatric population, direct aneurysm clipping has proved to be the most definitive and durable treatment for such lesions, but it is often hazardous and at times impossible to perform because of difficult surgical access, the incorporation of a parent vessel and/or perforators, and requisite proximal arterial ligation or trapping. Since the introduction of first-generation neurovascular stents into the endovascular surgery armamentarium in the late 1990s, SAC embolization has become a safe and effective option in adults to treat intracranial wide-necked aneurysms. 8, 11, 13, 21 Initially designed to act as a scaffold to prevent intrasaccular coil protrusion into the parent artery lumen, 34 these stents have been shown to divert blood from the aneurysm inflow zone, to promote intraaneurysmal stasis and thrombosis and thereby prevent or reduce coil compaction by changing intraaneurysmal flow, 15 and to provide luminal matrix for orifice endothelialization. 3, 17, 18 The art of embolization requires a delicate balance between the need to pack a fragile aneurysm optimally to prevent hemorrhage and the risk of intraprocedural aneurysm rupture and coil herniation. Often, a residual aneurysm neck or fundus is left behind on the immediate postcoiling angiogram. In our patient, we purposely kept the base of the aneurysm patent, as the aneurysm neck harbored lenticulostriate perforating vessels. Follow-up MRA at 2, 6, 12, 18, and 24 months postembolization revealed complete occlusion of the dome with stable aneurysm neck filling and partial normalization of the carotid artery lumen. Contrast-enhanced MRA (CE-MRA) showed patent proximal and distal right MCA segments and demonstrated flow contrast opacification equal to that of the left MCA (Fig. 4) . In addition, no evidence of ischemia was observed on follow-up MRI, correlating with the nonfocal neurological examination. Our group favors CE-MRA over time-of-flight MRA for the follow-up of coiled aneurysms, given the significant artifacts related to the latter technique. Time-of-flight MRA is based on the direction of protons flowing into the imaging voxel. Flowrelated artifacts can occur if nonlaminar flow is present. These artifacts can be exaggerated from the metal artifact related to the coil mass within the aneurysm. Contrastenhanced MRA is similar to digital subtraction angiography (DSA) since they both measure opacification of the vessel lumen.
The significance of a residual nonprogressive neck is uncertain and the center of current debate. Studies in adult populations have shown that angiographic recanalization of a coiled aneurysm has a rerupture rate of 0.57%-1.1%, and reintervention appears to be safe. 32 Despite the low annual rerupture rates, the long-term cumulative risk is not negligible in children; therefore, the necessity of lifelong angiographic follow-up must be considered in the equation when choosing the best treatment modality. This is particularly true in pediatric patients with ruptured intracranial aneurysms, who have a higher risk of developing new aneurysms and new subarachnoid hemorrhages than the average population. 16 Given the lack of longterm follow-up in young patients treated with endovascular technology, we obtain yearly CE-MRA studies for 5 years to understand the durability of treatment as well as to evaluate patency of the stented vessel. At the end of the 5 years, we perform DSA and correlate those findings with the CE-MRA findings. If there is good correlation, then we follow up with CE-MRA at 2-year intervals for 10 years, at which time another DSA is performed. Thereafter, CE-MRA is performed at 5-year intervals indefinitely. The idea is to avoid routine CT angiography (CTA), as there are metallic artifacts from the coils and stent on CTA, obscuring lumen patency. Moreover, there is radiation toxicity associated with CTA and DSA.
An important issue to consider in SAC embolization is the need for a pre-and postprocedural antiplatelet/anticoagulation protocol. In adult populations, the dual antiplatelet regimen of acetylsalicylic acid and clopidogrel has become a recommended regimen (despite the remaining controversy in the dosage and duration of treatment), as the two agents act synergistically to reduce chances of thromboembolism events and stent thrombosis. 10, 35 However, long-term outcomes and the value and risk of using an antiplatelet regimen in this young population are still to be determined both in ruptured and unruptured aneurysms.
Conclusions
Pediatric intracranial aneurysms are rare and challenging entities that require innovative treatment strategies to exclude the aneurysm dome and preserve the patency of the parent circulation. These challenges must be overcome regardless of whether endovascular or surgical therapy is selected. Endovascular therapy offers a safe and effective alternative to open microsurgery, but the durability of treatment and life-long angiographic follow-up must be considered in the treatment algorithm based on the remaining life expectancy in the pediatric population. Our experience suggests that endovascular intervention techniques with vascular reconstruction are potentially safe and effective in infants and could further improve prognosis. However, further studies are required to confirm our findings.
